MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
7052.73%
Quick Ratio
7052.73%
Cash Ratio
2730.74%
Debt to Asset Ratio
1.47%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities at fair va...
    • Cash and cash equivalents
    • Right-of-use asset and other non...
    • Property, plant and equipment, n...
Liabilities Breakdown
    • Total stockholders equity (defic...
    • Total liabilities
    • Subscription receivable
    • Others

Balance Sheets
2026-06-30
2026-03-31
2025-12-31
Cash and cash equivalents
319,333 168,412 21,766
Marketable securities at fair value
500,561 222,385 120,096
Prepaid expenses and other current assets
4,852 6,272 10,632
Total current assets
824,746 397,069 152,494
Property, plant and equipment, net
41 21 22
Right-of-use asset and other non-current assets
948 266 103
Total non-current assets
989 287 125
Total assets
825,735 397,356 152,619
Accounts payable
5,920 1,071 2,126
Accrued expenses
5,395 5,606 6,979
Other current liabilities and lease liabilities
379 39 47
Total current liabilities
11,694 6,716 9,152
Lease liabilities - non-current
428 0 4
Total liabilities
12,122 6,716 9,156
Redeemable convertible preferred stock-Series APreferred Stock
0 0 36,860
Redeemable convertible preferred stock-Series BPreferred Stock
0 0 78,903
Redeemable convertible preferred stock-Series CPreferred Stock
0 0 150,563
Subscription receivable
0 0 1,849
Common stock, 0.00001 par value, 200,000,000 and 267,466,797 shares authorized as of june30, 2026 and december31, 2025, respectively and 41,780,136 and 749,760 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
1 1 1
Additional paid-in capital
989,258 543,044 2,346
Subscription receivable
596 1,228 -
Accumulated other comprehensive (loss) income
-895 -524 60
Accumulated deficit
-174,155 -150,653 -123,421
Total stockholders equity (deficit)
813,613 390,640 -121,014
Total liabilities, redeemable convertible preferred stock, and stockholders equity (deficit)
825,735 397,356 152,619
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities atfair value$500,561K Cash and cashequivalents$319,333K Prepaid expenses andother current assets$4,852K Right-of-use asset and othernon-current assets$948K Property, plant andequipment, net$41K Total current assets$824,746K Total non-currentassets$989K Total assets$825,735K Total liabilities,redeemable convertible...$825,735K Total stockholdersequity (deficit)$813,613K Total liabilities$12,122K Accumulated deficit-$174,155K Accumulated othercomprehensive (loss) income-$895K Subscription receivable$596K Additional paid-in capital$989,258K Total currentliabilities$11,694K Lease liabilities -non-current$428K Common stock, 0.00001par value,...$1K Accounts payable$5,920K Accrued expenses$5,395K Other currentliabilities and lease...$379K

Veradermics, Inc (MANE)

Veradermics, Inc (MANE)